Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Fitchett

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Stroke|February 14, 2009
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?Gustavo Saposnik, Shaun G Goodman, Lawrence A Leiter, et al.
American Heart Journal|November 24, 2007
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcomeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
CJC Open|September 30, 2020
Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary SyndromeDavid H Fitchett, Lawrence A Leiter, Peter Lin, et al.
The American Journal of Cardiology|October 30, 2010
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatientsVineet Bhan, Raymond T Yan, Lawrence A Leiter, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2010
Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after dischargeAlan J Bagnall, Andrew T Yan, Raymond T Yan, et al.
American Heart Journal|January 31, 2006
Age-related differences in the management and outcome of patients with acute coronary syndromesRaymond T Yan, Andrew T Yan, Mary Tan, et al.
American Heart Journal|August 1, 2006
ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratificationAndrew T Yan, Raymond T Yan, Mary Tan, et al.
The Canadian Journal of Cardiology|November 29, 2011
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 1: non-ST-segment elevation ACSDavid H Fitchett, Pierre Theroux, James M Brophy, et al.
The Canadian Journal of Cardiology|November 29, 2011
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 2: ST-segment elevation myocardial infarctionDavid H Fitchett, Pierre Theroux, James M Brophy, et al.
European Heart Journal|February 11, 2011
Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Andrew T Yan, Raymond T Yan, Warren J Cantor, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Stroke|February 14, 2009
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?Gustavo Saposnik, Shaun G Goodman, Lawrence A Leiter, et al.
American Heart Journal|November 24, 2007
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcomeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
CJC Open|September 30, 2020
Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary SyndromeDavid H Fitchett, Lawrence A Leiter, Peter Lin, et al.
The American Journal of Cardiology|October 30, 2010
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatientsVineet Bhan, Raymond T Yan, Lawrence A Leiter, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2010
Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after dischargeAlan J Bagnall, Andrew T Yan, Raymond T Yan, et al.
American Heart Journal|January 31, 2006
Age-related differences in the management and outcome of patients with acute coronary syndromesRaymond T Yan, Andrew T Yan, Mary Tan, et al.
American Heart Journal|August 1, 2006
ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratificationAndrew T Yan, Raymond T Yan, Mary Tan, et al.
The Canadian Journal of Cardiology|November 29, 2011
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 1: non-ST-segment elevation ACSDavid H Fitchett, Pierre Theroux, James M Brophy, et al.
The Canadian Journal of Cardiology|November 29, 2011
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 2: ST-segment elevation myocardial infarctionDavid H Fitchett, Pierre Theroux, James M Brophy, et al.
European Heart Journal|February 11, 2011
Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Andrew T Yan, Raymond T Yan, Warren J Cantor, et al.
Pageof 6